WHO ICTRP trial

PFBC-Registry "Fahr-NET": Registry study for clinical and genetic…

DRKS00037946 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00037946
Public title PFBC-Registry "Fahr-NET": Registry study for clinical and genetic characterization, biomarker development, and establishment of a cohort for future clinical therapy development.
Scientific title PFBC-Registry "Fahr-NET": Registry study for clinical and genetic characterization, biomarker development, and establishment of a cohort for future clinical therapy development. - PFBC-Registry "Fahr-NET"
Primary sponsor Klinik für Neurologie der Universitätsklinik Ulm (RKU Ulm)
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type observational
Countries Germany
Conditions PFBC (synonyms Fahr disease, PBGC, symmetric basal ganglia calcification, etc.) ORPHA:1980
Interventions Group 1: Patients diagnosed with PFBC (synonym Fahr's disease, PBGC, symmetric basal ganglia calcification, etc.) undergo a neurological examination every 12 months (i.e., T1 + all follow-up examinations). In order to objectively evaluate…
Registration date Sep 29, 2025
Target size 60
Secondary IDs 125/25
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations